Related Experiment Video
Updated: May 24, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
A Macaca mulatta model of fulminant hepatic failure
1Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
World Journal of Gastroenterology
|February 21, 2012
Summary
Researchers developed a primate model for fulminant hepatic failure (FHF) using toxins. This model closely mimics human FHF cases, aiding future research into disease mechanisms and therapies.
Area of Science:
- Hepatology
- Toxicology
- Primate Models
Background:
- Fulminant hepatic failure (FHF) is a rare but severe condition with high mortality.
- Establishing appropriate animal models is crucial for understanding FHF pathogenesis and developing treatments.
Purpose of the Study:
- To establish a large primate model of fulminant hepatic failure (FHF).
- To characterize the clinical, biochemical, and histopathological progression of the FHF model.
Main Methods:
- Intraperitoneal infusion of amatoxin and endotoxin in Macaca mulatta.
- Dynamic monitoring of clinical features, biochemical markers, histopathology, and imaging (MRI, ultrasonography).
Main Results:
- Toxin administration led to increased liver enzymes and bilirubin, decreased coagulation, and characteristic liver pathology (steatosis, necrosis, yellow atrophy).
- Hepatic encephalopathy, including coma and cerebral edema, was observed.
- Imaging confirmed progressive hepatic and cerebral abnormalities.
Conclusions:
- An appropriate large primate model of FHF has been successfully established.
- The model closely resembles human FHF cases.
- This model is suitable for investigating FHF mechanisms and evaluating therapeutic interventions.
